Cargando…

Proteasome modulator 9 and macrovascular pathology of T2D

AIMS: Coronary artery disease (CAD) and stroke share a major linkage at the chromosome 12q24 locus. The same chromosome region entails at least a major risk gene for type 2 diabetes (T2D) within NIDDM2, the non-insulin-dependent-diabetes 2 locus. The gene of Proteasome Modulator 9 (PSMD9) lies in th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gragnoli, Claudia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102609/ https://www.ncbi.nlm.nih.gov/pubmed/21496327 http://dx.doi.org/10.1186/1475-2840-10-32

Ejemplares similares

Proteasome Modulator 9 SNPs are linked to hypertension in type 2 diabetes families
por: Gragnoli, Claudia
Publicado: (2011)

T2D and Depression Risk Gene Proteasome Modulator 9 is Linked to Insomnia
por: Hao, Han, et al.
Publicado: (2015)

Macrovascular complication phenotypes in type 2 diabetic patients
por: Papa, Giuseppe, et al.
Publicado: (2013)

Hypercholesterolemia and a candidate gene within the 12q24 locus
por: Gragnoli, Claudia
Publicado: (2011)

Overweight condition and waist circumference and a candidate gene within the 12q24 locus
por: Gragnoli, Claudia
Publicado: (2013)

The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates
por: Al-Maskari, Fatma, et al.
Publicado: (2007)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study
por: Cardoso, Claudia R. L., et al.
Publicado: (2021)

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
por: Yoon, Hye-jin, et al.
Publicado: (2015)

Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus
por: Wang, Shenqi, et al.
Publicado: (2013)

Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy
por: van Ark, Joris, et al.
Publicado: (2013)

Low 25-hydroxyvitamin D(2) and 25-hydroxyvitamin D(3) levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study
por: Engelen, Lian, et al.
Publicado: (2015)

Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
por: Cardoso, Claudia R. L., et al.
Publicado: (2020)

Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study
por: Cardoso, Claudia R. L., et al.
Publicado: (2019)

Associations of Serum Uric Acid Levels With Macrovascular and Renal Microvascular Dysfunction Among Individuals From Sub-Saharan Africa
por: Hayfron-Benjamin, Charles F., et al.
Publicado: (2021)

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria
por: Sibal, Latika, et al.
Publicado: (2009)

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
por: Cardoso, C. R. L., et al.
Publicado: (2018)

Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes
por: Sell, David R., et al.
Publicado: (2016)

Abnormal modulation of reward versus punishment learning by a dopamine D2-receptor antagonist in pathological gamblers
por: Janssen, Lieneke Katharina, et al.
Publicado: (2015)

Facial mimicry is not modulated by dopamine D2/3 and opioid receptor antagonism
por: Korb, Sebastian, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Genetics of macrovascular complications in type 2 diabetes
por: Tonyan, Ziravard N, et al.
Publicado: (2021)

Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 Diabetes
por: Casella, Sara, et al.
Publicado: (2015)

Species-specific protein–protein interactions govern the humanization of the 20S proteasome in yeast
por: Sultana, Sarmin, et al.
Publicado: (2023)

Precise Replacement of Saccharomyces cerevisiae Proteasome Genes with Human Orthologs by an Integrative Targeting Method
por: Yellman, Christopher M.
Publicado: (2020)

Protective role of NRF2 in macrovascular complications of diabetes
por: Wu, Junduo, et al.
Publicado: (2020)

Macrovascular Complications in Patients with Diabetes and Prediabetes
por: Huang, Dou, et al.
Publicado: (2017)

Endothelium in Coronary Macrovascular and Microvascular Diseases
por: Godo, Shigeo, et al.
Publicado: (2021)

Cost of diabetes mellitus and related macrovascular complications in Turkiye
por: Birinci, Suayip, et al.
Publicado: (2023)

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
por: Mavaddat, Nasim, et al.
Publicado: (2022)

Degradation Signals for Ubiquitin-Proteasome Dependent Cytosolic Protein Quality Control (CytoQC) in Yeast
por: Maurer, Matthew J., et al.
Publicado: (2016)

Massive expression of cysteine-containing proteins causes abnormal elongation of yeast cells by perturbing the proteasome
por: Namba, Shotaro, et al.
Publicado: (2022)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Rangel, Érika B., et al.
Publicado: (2019)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
por: Kim, Jung Hee, et al.
Publicado: (2011)

Heart in Diabetes: Not Only a Macrovascular Disease
por: Stratmann, Bernd, et al.
Publicado: (2011)

Implementation of dCas9-mediated CRISPRi in the fission yeast Schizosaccharomyces pombe
por: Ishikawa, Ken, et al.
Publicado: (2021)

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
por: Ott, Christian, et al.
Publicado: (2017)

Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
por: Hu, Yonghui, et al.
Publicado: (2021)

Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes
por: Cardoso, Claudia R. L., et al.
Publicado: (2016)

Genetic Interactions Between BOB1 and Multiple 26S Proteasome Subunits Suggest a Role for Proteostasis in Regulating Arabidopsis Development
por: Silverblatt-Buser, Elan W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_acfa9g4jsln04ro1uf280sq74r